The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
He has published more than 100 research papers in several prestigious national and international journals
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Through lifestyle modifications, ADORE will assess the progress of patients based on parameters like reduction in blood sugar levels and weight, among others
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Nutrigenomics is the study of how genes and diet (nutrients) interact. Gene variants (genetic differences) predict how an individual’s body will respond to certain nutrients.
Subscribe To Our Newsletter & Stay Updated
